Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 118.00M | £ 73.00M | £ 72.00M | £ 154.00M | £ 196.00M |
Total Assets | £ 9.12B | £ 9.84B | £ 9.20B | £ 8.88B | £ 10.31B |
Total Debt | £ 2.04B | £ 2.75B | £ 2.45B | £ 2.54B | £ 3.31B |
Net Debt | £ 1.92B | £ 2.67B | £ 2.38B | £ 2.39B | £ 3.12B |
Total Liabilities | £ 2.52B | £ 3.11B | £ 2.95B | £ 2.89B | £ 3.93B |
Stockholders Equity | £ 6.58B | £ 6.72B | £ 6.23B | £ 5.92B | £ 6.29B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |